In the world of AI, life sciences is an exciting space to work. New models and algorithms appear almost on a daily basis, helping us to understand how biology works, and how we can do things like diagnosing human health, designing new drugs, or building new microbial cell factories. It is at the ...
.jpg)
BioLizard, a leader in multi-omics integration and AI-powered biopharma analytics, is pleased to announce the appointment of Dr. Alexander Scheer as Chief Scientific Officer (CSO). Dr. Scheer is a highly respected R&D executive with a track record of advancing therapies from discovery to ...
As we gear up for the final stretch of the year, BioLizard enters the autumn season with renewed energy and momentum. The company has delivered a standout first half of 2025, marked by international recognition, groundbreaking AI innovation, and strategic expansion. With major awards, new product ...
.jpg)
